Eversept Partners’s UroGen Pharma URGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-74,797
Closed -$774K 75
2023
Q2
$774K Buy
+74,797
New +$774K 0.06% 62